Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
ViewRay receives order for up to 14 MRIdian Systems from GenesisCare » 08:40
06/24/21
06/24
08:40
06/24/21
08:40
VRAY

ViewRay

$5.92 /

+0.1 (+1.72%)

ViewRay announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

06/14/21 Piper Sandler
ViewRay shares should attract more investor interest, says Piper Sandler
05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

Hot Stocks
ViewRay expands partnership with GenesisCare » 06:13
06/24/21
06/24
06:13
06/24/21
06:13
VRAY

ViewRay

$5.92 /

+0.1 (+1.72%)

GenesisCare announced it…

GenesisCare announced it expanded its partnership with ViewRay by purchasing new MRIdian MR-Guided Therapy Systems to offer radiation therapy. The MRIdian system provides oncologists acute visualization through diagnostic-quality MR images and the ability to adapt to target cancer in real-time. The systems will be installed in U.S. locations first, beginning with Fort Myers, Florida, then expanding across the United Kingdom and beyond.

ShowHide Related Items >><<
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

06/14/21 Piper Sandler
ViewRay shares should attract more investor interest, says Piper Sandler
05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

Over a week ago
Recommendations
ViewRay shares should attract more investor interest, says Piper Sandler » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
VRAY

ViewRay

$5.80 /

+0.05 (+0.87%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar introduced 2023 estimates for ViewRay, including orders of 30 units and total revenue of $141M. A quicker pace of installs should have positive margin implications, and the combination of "premium revenue growth and margin expansion will have a corresponding positive effect on the multiple at which shares trade," Bednar tells investors in a research note. He believes the stock should attract investor interest as its backlog conversion rates improve and both revenue and margin trends move higher. Bednar keeps an Overweight rating on ViewRay with a $7 price target.

ShowHide Related Items >><<
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.80 /

+0.05 (+0.87%)

Over a month ago
Upgrade
ViewRay upgraded to Buy from Neutral at Guggenheim » 06:15
05/07/21
05/07
06:15
05/07/21
06:15
VRAY

ViewRay

$4.79 /

-0.015 (-0.31%)

Guggenheim analyst Chris…

Guggenheim analyst Chris Pasquale upgraded ViewRay to Buy from Neutral with a $7 price target.

ShowHide Related Items >><<
VRAY ViewRay
$4.79 /

-0.015 (-0.31%)

VRAY ViewRay
$4.79 /

-0.015 (-0.31%)

03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
VRAY ViewRay
$4.79 /

-0.015 (-0.31%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$4.79 /

-0.015 (-0.31%)

Earnings
ViewRay reports Q1 EPS (17c), consensus (17c) » 16:04
05/06/21
05/06
16:04
05/06/21
16:04
VRAY

ViewRay

$4.77 /

-0.04 (-0.83%)

Reports Q1 revenue…

Reports Q1 revenue $15.5M, consensus $12.89M. "Our performance in the first quarter 2021 represents a solid step forward and progress on our mission to improve the paradigm of care for cancer patients globally," said Scott Drake, President and CEO. "Our clinical and innovation pipelines are driving commercial traction. We look forward to upcoming clinical trial data and advancements in our product pipeline which we expect will fuel future growth."

ShowHide Related Items >><<
VRAY ViewRay
$4.77 /

-0.04 (-0.83%)

VRAY ViewRay
$4.77 /

-0.04 (-0.83%)

03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
VRAY ViewRay
$4.77 /

-0.04 (-0.83%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$4.77 /

-0.04 (-0.83%)

Upgrade
ViewRay upgraded to Buy from Neutral at BTIG » 05:30
03/26/21
03/26
05:30
03/26/21
05:30
VRAY

ViewRay

$4.33 /

+0.31 (+7.71%)

BTIG analyst Marie…

BTIG analyst Marie Thibault upgraded ViewRay to Buy from Neutral with a $7 price target. The recovery in hospital capital equipment budgets, and positive management commentary during a chat this week points to MRIdian's "broadening appeal and improving visibility" on installation schedules, Thibault tells investors in a research note. As such, the analyst is "more bullish" on the mid-to-long-term outlook for ViewRay. Thibault's recent survey of 25 hospital purchasing decision-makers pointed to a "strong recovery" in overall capital equipment budgets over the next few months.

ShowHide Related Items >><<
VRAY ViewRay
$4.33 /

+0.31 (+7.71%)

VRAY ViewRay
$4.33 /

+0.31 (+7.71%)

01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
10/28/20
Fly Intel: Top five analyst upgrades
VRAY ViewRay
$4.33 /

+0.31 (+7.71%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$4.33 /

+0.31 (+7.71%)

Over a quarter ago
Conference/Events
ViewRay participates in a conference call with BTIG » 11:25
03/23/21
03/23
11:25
03/23/21
11:25
VRAY

ViewRay

$4.21 /

-0.115 (-2.66%)

Medical Technology &…

Medical Technology & Digital Health Analyst Thibault holds a conference call with management on March 23 at 12 pm hosted by BTIG.

ShowHide Related Items >><<
VRAY ViewRay
$4.21 /

-0.115 (-2.66%)

VRAY ViewRay
$4.21 /

-0.115 (-2.66%)

01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
10/28/20
Fly Intel: Top five analyst upgrades
VRAY ViewRay
$4.21 /

-0.115 (-2.66%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$4.21 /

-0.115 (-2.66%)

Conference/Events
ViewRay participates in a conference call with BTIG » 04:55
03/23/21
03/23
04:55
03/23/21
04:55
VRAY

ViewRay

$4.33 /

-0.105 (-2.37%)

Medical Technology &…

Medical Technology & Digital Health Analyst Thibault holds a conference call with management on March 23 at 12 pm hosted by BTIG.

ShowHide Related Items >><<
VRAY ViewRay
$4.33 /

-0.105 (-2.37%)

VRAY ViewRay
$4.33 /

-0.105 (-2.37%)

01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
10/28/20
Fly Intel: Top five analyst upgrades
VRAY ViewRay
$4.33 /

-0.105 (-2.37%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$4.33 /

-0.105 (-2.37%)

Conference/Events
ViewRay management to meet virtually with Piper Sandler » 04:55
03/18/21
03/18
04:55
03/18/21
04:55
VRAY

ViewRay

$4.49 /

-0.05 (-1.10%)

Virtual Meeting to be…

Virtual Meeting to be held on March 18 hosted by Piper Sandler.

ShowHide Related Items >><<
VRAY ViewRay
$4.49 /

-0.05 (-1.10%)

VRAY ViewRay
$4.49 /

-0.05 (-1.10%)

01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
10/28/20
Fly Intel: Top five analyst upgrades
VRAY ViewRay
$4.49 /

-0.05 (-1.10%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$4.49 /

-0.05 (-1.10%)

Conference/Events
ViewRay participates in a conference call with BTIG » 14:04
03/15/21
03/15
14:04
03/15/21
14:04
VRAY

ViewRay

$5.00 /

+0.235 (+4.93%)

Medical Technology &…

Medical Technology & Digital Health Analyst Thibault holds a conference call with management on March 23 at 12 pm hosted by BTIG.

ShowHide Related Items >><<
VRAY ViewRay
$5.00 /

+0.235 (+4.93%)

VRAY ViewRay
$5.00 /

+0.235 (+4.93%)

01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
01/04/21 Piper Sandler
Piper Sandler remains 'positively inclined' on ViewRay after preliminary results
11/06/20 Piper Sandler
ViewRay price target raised to $4 from $3.50 at Piper Sandler
10/28/20
Fly Intel: Top five analyst upgrades
VRAY ViewRay
$5.00 /

+0.235 (+4.93%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.00 /

+0.235 (+4.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.